Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Government has selected an operator for the exchange of blocked assets

3/11/24 MOEX

Rostelecom became an IP-telephony operator Mango Telecom

3/11/24 RTKM

Pharmacy Chain 36.6 reported for 2023 by RAS

3/11/24 APTK

Yandex Cloud neural network has learned to recognize emotions

3/11/24 YNDX

Transneft to increase oil shipments to East

3/11/24 TRNFP

Polymetal completed the sale of its Russian business

3/11/24 POLY

Tatneft agrees with SOCAR on cooperation in petrochemistry

3/8/24 TATN

Yandex shareholders approve restructuring

3/7/24 YNDX

Positive Technologies disclosed the parameters of additional share issue

3/7/24 POSI

CherMK's blast furnace was not damaged

3/7/24 CHMF